Skip to main content

QTD Income Equity – 3Q2024 vs R1000V


Market Observations & Portfolio Commentary

Income Equity – 3Q2024 vs Russell 1000 Value

 

Market Update

U.S. equities traded higher during Q3 with most of the major indices posting mid-single digit gains. The quarter was marked by significant market shifts, including inflation cooling, employment weakening, volatility spiking, and a larger-than-expected Federal Reserve rate cut, yet the stock market ended on a high note. The broader market, measured by the Russell 3000 Index, rose 6.2%. There was a notable rotation to small cap and value styles away from large cap growth. This fostered broader market participation, with a wider range of sectors participating, especially the rate sensitive areas. Looking at market factors, Yield and most Value factors posted the strongest returns while most of the Growth, Volatility, and Momentum factors presented headwinds. Quality factors had a mixed impact.

 

Key Performance Takeaways

  • The London Company Income Equity portfolio gained 10.5% (10.4% net) during the quarter vs. a 9.4% increase in the Russell 1000 Value Index. Sector exposure was a modest headwind more than offset by positive stock selection.

  • After struggling in the first half of the year, the Income Equity portfolio solidly outperformed the Russell 1000 Value index and our expectations 85-90% upside capture expectations in a robust return environment. Factors like increased volatility and surging market breadth favored our portfolios. Greater exposure to Yield factors as well as less exposure to Volatility and Momentum factors aided relative performance. We were encouraged to see the Income Equity portfolio protected on the downside amidst the volatility and market drawdown while staying ahead of its benchmark during the market’s sharp recovery.

 

Top 3 Contributors to Relative Performance 

  • Progressive Corporation (PGR) – PGR was a top performer year to date due to its success in growing the business and improving margins. PGR has gained market share from competitors and improved its margins by effectively segmenting underwriting risks and implementing strategic pricing. PGR has achieved its profitability target by lowering advertising costs and focusing on acquiring preferred customers. We remain confident in PGR’s ability to execute in all environments, competitive advantages, and capital allocation strategy.

  • Lowe’s Companies, Inc. (LOW) – LOW was a top performer due to the execution of its ongoing productivity initiatives, share gains, and margin improvement. The Pro business continues to post better than expected results due to LOW’s multiyear investments. LOW is in a good position to continue to gain share despite some moderation following the pandemic boom. LOW has a very strong balance sheet and returns cash to shareholders through dividends and share buybacks.

  • Starbucks Corporation (SBUX) – Despite the business’s current struggles, SBUX shares responded positively this quarter to the news of a CEO change. Formerly the CEO of Chipotle, Brian Niccol was named Chairman and CEO. In addition to Niccol’s impressive background, we believe that someone with deep QSR (quick-service restaurant) experience, which Laxman lacked, is an immediate improvement for the company. SBUX still needs to navigate through a pressured food service environment and self-inflicted operational issues, but we feel incrementally positive with Niccol at the helm.

 

Top 3 Detractors from Relative Performance 

  • Charles Schwab Corporation (SCHW) – SCHW were weak during 3Q, which led to underperformance vs. the broad market YTD. In its latest quarter, SCHW reported weaker results, though with little implications on company fundamentals. Cash sorting from consumers continued in the latest quarter and has persisted longer than we anticipated. We believe that an end to SCHW’s headwinds are near, especially as the Federal Reserve shifts to lower rates, and consequently, we expect a strong rebound in earnings power within the next 18 months. Longer term, we believe the company is well positioned to continue capturing market share and driving sustainable earnings growth.

  • Merck & Co., Inc. (MRK) – MRK continues to experience solid growth in key therapeutic areas, driven by its blockbuster immunotherapy treatment, Keytruda. However, MRK recently lowered its outlook for its HPV vaccine due to challenges in China, which has weighed on investor sentiment. Management attributes the demand decline to the delayed effects of China’s anti-corruption campaign and elevated inventory at its distribution partner. Despite these headwinds, they are confident in the vaccine’s long-term potential especially outside China. We remain attracted to MRK’s strong bullpen of drugs and vaccines and believe MRK’s leadership team can accelerate its drug pipeline and supplement growth with business development opportunities.

  • Microsoft Corporation (MSFT) – Shares of MSFT posted a modest decline during 3Q. MSFT continues to post strong results (15% revenue growth in the latest quarter) driven by cloud and AI purchases by customers. However, valuation based on near term estimates is high at 24x EV/EBITDA, which may have contributed to the relative weakness. In addition, the recent Activision acquisition added some noise to the reported numbers.

 

Sector Influence

We are bottom-up stock pickers, but sector exposures influenced relative performance as follows:

  • What Helped: Underweight Energy (a weaker performing sector) & overweight Cons. Staples (a better performing sector)

  • What Hurt: Overweight Info. Technology (a weaker performing sector) & underweight Utilities (a better performing sector)

 

Trades During the Quarter

  • Increased: TE Connectivity (TEL) – Late in Q3, we added 1% to the existing position in TEL. We initiated our position during Q2, and this recent addition brought the position size close to the 3% weighting that we often target for new positions. We reduced cash in the portfolio to make the addition.

 

Looking Ahead

Stocks enter 4Q in good form, but challenges remain. The market appears priced for near perfection, with expectations of a soft landing and healthy earnings growth driving the S&P 500 to a lofty valuation that leaves little room for error. The Fed’s recent rate cut may sow the seeds for a cyclical recovery, but whether the economic impact arrives in time to avoid a downturn is uncertain. Lower rates tend to support market sentiment and multiples in the short term, but it can take up to two years for policy changes to impact economic and earnings data. Meanwhile, rates remain in restrictive territory. Therefore, the impact of restrictive policy may continue to affect the economy in the months ahead. While we believe that the odds of a near term recession are low, we note the difficulty in navigating a soft landing. 

In terms of the equity market, valuations based on near term earnings are elevated in the context of moderate GDP growth. We believe that equity returns in the near term may be modest, with shareholder yield (dividends, share repurchase, debt reduction) comprising a significant percentage of the total return from equities. Moreover, as a large corporate debt maturity wall approaches, balance sheet strength will likely become a differentiator and an advantage for investors focused on fundamentals. We believe our focus on quality, diversification, and valuation will continue to reinforce our margin of safety, positioning our portfolios for success in this uncertain climate.

 

We believe our focus on quality, diversification, and valuation will continue to reinforce our margin of safety, positioning our portfolios for success in this uncertain climate.

 

Annualized Returns 

As of 9/30/2024

Income Equity - 3Q2024 vs R1000V Annualized Returns

Inception date: 12/31/1999. Past performance should not be taken as a guarantee of future results. Performance is preliminary. Subject to change.

You are now leaving The London Company’s website. The link below is provided as a convenience, and The London Company is not responsible for the content provided on the destination site.

Continue